Kathmandu
Cancer Center
Kathmandu
Cancer Center
From HPV vaccination to Image-Guided Brachytherapy — complete cervical cancer care is available at Kathmandu Cancer Center. Before travelling to India, speak to us once.
Cervical cancer starts in the cervix — the narrow passage that connects the uterus to the vagina. Almost every case is caused by Human Papillomavirus (HPV), one of the world's most common infections. Most people clear it naturally, but in some women the virus persists for years and, over time, causes normal cells to change.
This change happens slowly — often over 10 to 20 years. That long window before cancer fully develops is what makes screening so powerful: we can find these pre-cancerous changes and treat them before they ever become cancer.
In Nepal, cervical cancer is the second most commonly diagnosed cancer in women, and most patients arrive at a late stage — not because treatment was unavailable, but because screening was missed and early symptoms were dismissed. That is the tragedy this page is trying to address.
Most women with early cervical cancer feel completely normal. That is precisely why the warning signs below — when they do appear — must be taken seriously.
Cervical cancer is among the most preventable cancers that exist. Three things, used together, can reduce a woman's lifetime risk to almost nothing.
Cervical cancer has a pre-invasive phase that lasts up to 20 years. Screening finds these changes and treats them before they ever become cancer — one of the most effective interventions in all of medicine.
| Test | Who it's for | How often | What it finds | At KCC |
|---|---|---|---|---|
| VIA Visual Inspection |
Women 30+, any setting | Every 3–5 years | White patches showing pre-cancer; result in minutes | ✓ Yes |
| Pap Smear | Women from age 21 | Every 3 years | Abnormal cells on the cervix | ✓ Yes |
| HPV DNA Test Preferred 30+ |
Women 30–65 | Every 5 years | High-risk HPV strains — most sensitive screening available | ✓ Yes |
| Colposcopy + Biopsy | Abnormal Pap / HPV / VIA | When indicated | Precise extent of CIN; definitive diagnosis | ✓ Yes |
| LEEP / LLETZ | CIN 2–3 confirmed | Once (curative) | Removes pre-cancerous area entirely — prevents cancer | ✓ Yes |
Every patient follows a structured, internationally recognised sequence. Here is what to expect from first visit to follow-up.
We begin with a colposcopy-guided biopsy to confirm the diagnosis. This is followed by pelvic MRI to map the tumour precisely, and a CT scan to check whether cancer has spread beyond the cervix. Staging is assigned using FIGO 2018 criteria — this determines your treatment plan.
Your case is discussed at KCC's weekly joint tumour board — gynaecological surgeons, radiation oncologists and medical oncologists together. No single specialist decides alone. A treatment plan is built around your stage, your tumour's characteristics, your fertility wishes, and your overall health. You will be told exactly what is recommended and why.
Depending on your stage, you will proceed to either: radical surgery (for early disease, Stage IA2–IIA), or concurrent chemoradiation (for locally advanced disease, Stage IIB and beyond). Both approaches are curative in intent. Fertility wishes are discussed before treatment begins in all women of reproductive age.
For patients receiving chemoradiation, IGBT is the essential final step. A radiation source is placed directly inside the tumour under MRI or CT guidance — typically 3 to 5 sessions. This delivers a concentrated curative dose to remaining cancer cells while protecting the bladder, rectum and bowel immediately around them. Omitting brachytherapy reduces cure rates by 10–12 percentage points. KCC introduced IGBT first in Nepal in 2022 and follows GEC-ESTRO international protocols.
After treatment ends, KCC follows up at 3 months, then every 3 months for 2 years, then 6-monthly to 5 years. Imaging is arranged as needed. Lymphoedema management, sexual health support, and psychological care are available within KCC. Our goal is not just cure — it is a full return to life.
Send your biopsy, MRI or previous treatment summary via WhatsApp. Our team reviews within 24 hours and advises you directly — no travel needed for an initial assessment.
📤 Send Reports via WhatsAppKCC provides the complete spectrum of treatment — all under one roof. Your plan will depend on stage, tumour size, and what matters to you.
Brachytherapy places a radioactive source directly inside the tumour cavity, so the radiation goes exactly where it is needed. In IGBT, real-time MRI or CT imaging guides the exact placement — meaning the dose is shaped to each patient's individual tumour, not a generic plan.
Clinical evidence consistently shows that completing chemoradiation without brachytherapy reduces long-term survival by 10–12 percentage points. It is not optional. KCC is the only centre in Nepal where full MRI/CT-guided IGBT is available, which is why most patients no longer need to go abroad.
The treatment approach, timeline and goals differ depending on the stage at diagnosis. Both are treated with curative intent at KCC.
Complete care. International protocols. Your family close by.
Our gynaecological oncology team brings surgical, radiation and medical expertise together — so care is coordinated from the start, not referred from one specialist to the next.
Answers to what we hear most from patients and their families.
Whether you need screening, a second opinion, or want to start treatment — our team is ready. Most patients get an appointment within 48 hours.
पाठेघरको मुखको क्यान्सरको बारेमा सम्पूर्ण जानकारी — लक्षण, रोकथाम, र KCC मा उपलब्ध उपचार — नेपाली भाषामा पढ्न सक्नुहुन्छ।
Book Appointment